Wednesday, July 8, 2026
🇺🇸 FDA

Drug profile · INN

hydrocortisone butyrate

HYDROCORTISONE BUTYRATE

hydrocortisone butyrate (HYDROCORTISONE BUTYRATE) is a glucocorticoid receptor agonist. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: topical. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 20
Pipeline programs 0
News articles 0
Drug details — hydrocortisone butyrate
US status
approved
Class
—
Route
TOPICAL
Patents
20
Programs
0
Data quality
0.89
← All drugs Manufacturer profile Related patents Drug news hub Event calendar

Quick answer

hydrocortisone butyrate (HYDROCORTISONE BUTYRATE) is a glucocorticoid receptor agonist. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN hydrocortisone butyrate
Brand HYDROCORTISONE BUTYRATE
Mechanism Glucocorticoid receptor agonist
Target Glucocorticoid receptor
Route TOPICAL
Formulation LOTION
Originator Chongqing Precision Biotech Co., Ltd

Mechanism of action

Glucocorticoid receptor agonist

Primary target: Glucocorticoid receptor

Approval history

Authority Status Date
FDA approved —

Related & competitor drugs

Browse all drugs
  1. beclomethasone dipropionate Glucocorticoid receptor agonist
  2. betamethasone acetate Glucocorticoid receptor agonist
  3. betamethasone dipropionate Glucocorticoid receptor agonist
  4. betamethasone valerate Glucocorticoid receptor agonist
  5. budesonide Alimentary tract and metabolism (A07)
  6. clobetasol propionate Glucocorticoid receptor agonist

Related patents

Browse patents Chongqing Precision Biotech Co., Ltd patent hub

  1. US 12233135

    Therapeutic constructs for treating cancer

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12162920

    Hinge area and use of same in constructing car skeleton

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12054501

    Compositions and methods for inhibiting arginase activity

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11931453

    Drug delivery device

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11866747

    Engineered meganucleases that target human mitochondrial genomes

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11826392

    Purification method of fungal cell wall composition

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11490643

    Lactobacillus casei for treating obesity and associated metabolic disorders

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11317888

    Non-invasive method for pressure measurement

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11191935

    Implant delivery system with hydration promotor capability

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11129791

    Drug delivery device

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11078245

    Colon and pancreas cancer peptidomimetics

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10792481

    Implantable drug delivery device

    Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10662440

    Self-limiting viral vectors encoding nucleases

    Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10653169

    Food thickening agent, method for producing food thickening agent

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10533040

    Colon and pancreas cancer peptidomimetics

    Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10525248

    Apparatus and method for promoting fluid uptake into an implant

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10327461

    Food thickening agent, method for producing food thickening agent

    Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10214721

    Method for making culture medium

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10105523

    Implantable drug delivery device

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10006052

    Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereof

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is hydrocortisone butyrate?

hydrocortisone butyrate (HYDROCORTISONE BUTYRATE) is a glucocorticoid receptor agonist. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for hydrocortisone butyrate?

HYDROCORTISONE BUTYRATE is a marketed brand name for hydrocortisone butyrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of hydrocortisone butyrate?

hydrocortisone butyrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.